ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
81.875
0.00%
Bitcoin
66,834.43
-0.50%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. HLS Therapeutics Inc (HLS) Quote

HLS Therapeutics Inc

HLS Therapeutics Inc (HLS)

Healius Limited
3.34
0.14
(4.37%)
Closed July 21 4:12PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.34
Bid
3.25
Ask
3.40
Volume
1,801
3.20 Day's Range 3.20
3.18 52 Week Range 6.53
Market Cap
102.336M
Previous Close
3.20
Open
3.20
Last Trade
100
@
3.335
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,043
Shares Outstanding
31,980,000
Dividend Yield
-
PE Ratio
-3.72
Earnings Per Share (EPS)
-0.86
Revenue
63.61M
Net Profit
-27.53M

About HLS Therapeutics Inc

Sector
Pharmaceutical Preparations
Industry
Motor Vehicle Part,accessory
Website
www.hlstherapeutics.com
Headquarters
Toronto, Ontario, Can
Founded
2018
HLS Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker HLS. The last closing price for HLS Therapeutics was $3.20. Over the last year, HLS Therapeutics shares have traded in a share price range of $ 3.18 to $ 6.53.

HLS Therapeutics currently has 31,980,000 shares outstanding. The market capitalization of HLS Therapeutics is $102.34 million. HLS Therapeutics has a price to earnings ratio (PE ratio) of -3.72.

HLS Latest News

More News

HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust

HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust Canada NewsWire TORONTO, July 2, 2024 Total consideration of up to $45.75 million, which...

July 02 2024
PR Newswire (Canada)

HLS Therapeutics Reports Annual Meeting Results

HLS Therapeutics Reports Annual Meeting Results Canada NewsWire TORONTO, June 7, 2024 TORONTO, June 7, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS...

June 07 2024
PR Newswire (Canada)

New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment

New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment Canada NewsWire DORVAL, QC, May 28, 2024 Real world evidence demonstrates...

May 28 2024
PR Newswire (Canada)

HLS Therapeutics Announces Q1 2024 Financial Results

HLS Therapeutics Announces Q1 2024 Financial Results Canada NewsWire TORONTO, May 9, 2024 TORONTO, May 9, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX:...

May 09 2024
PR Newswire (Canada)

HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call

HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO, April 25, 2024 TORONTO, April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...

April 25 2024
PR Newswire (Canada)

HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire TORONTO, April 9, 2024 TORONTO, April 9, 2024 /CNW/ - HLS Therapeutics Inc. (HLS or...

April 09 2024
PR Newswire (Canada)

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups Canada NewsWire TORONTO, April 8, 2024 Findings Presented...

April 08 2024
PR Newswire (Canada)

HLS Therapeutics Announces Fiscal 2023 Financial Results

HLS Therapeutics Announces Fiscal 2023 Financial Results Canada NewsWire TORONTO, March 14, 2024 TORONTO, March 14, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company"...

March 14 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.16-4.571428571433.53.793.1816273.38062216CS
4-0.13-3.746397694523.473.793.1827313.46349075CS
12-1.06-24.09090909094.44.83.1840433.68631284CS
26-0.87-20.66508313544.215.483.1872604.00528703CS
52-3.17-48.69431643636.516.533.1890124.29076557CS
156-14.23-80.990324416617.5720.523.18186439.72878713CS
260-14.89-81.678551837618.2325.913.183023714.76118956CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
226.82M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
217.11M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
188.2M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M

Discussion

View Full Feed
john1311 john1311 3 minutes ago
thanks for all the excellent postings you do here... you make this one of the most informative boars on ihub....
TCNNF
rikkie rikkie 4 minutes ago
BUT NO DEBT!!!
LWLG
NASDAQ2020 NASDAQ2020 8 minutes ago
And Tuesday .

ELTP
ELTP
highlandernew highlandernew 11 minutes ago
🔴🔴Nebuchad, World's LARGEST movie co. under $1B M-Cap?:

¢0.50 cents (12.8x)?

Real shares are Apex property #2 of HUMAN RACE ?

https://investorshub.advfn.com/u
AMC
tenac tenac 11 minutes ago
Ok...im kinda sorta caught us on my reading here....y'all have a awesome day!
RealDutch RealDutch 17 minutes ago
Basically all they have to do is explain that these investments generate stable income and are not exposed to fluctuations and overvaluations in the stock market. There, I needed only 1 sentence.
ITUP
fuzzy fuzzy 18 minutes ago
9-45-22-54,,,,thanks
edbi46 edbi46 21 minutes ago
Anyone with a 1/4 of a brain can see through MANIPULATIVE and MISLEADING way linked post is structured!!! ALL PAID BASHERS are LIARS/MANIPULATORS/MISLEADERS/PROVOCATEURS, without exceptions ( even LESS BRAINS one needs to have, to UNDERSTAND, that i wright/type fast and don't have time to spell chec
SAI WBA
RealDutch RealDutch 21 minutes ago
I agree Snow. Needs some work. Laxmi can pass it on.

Also, we are doing plantations now. Which is very different from gold /rice / aviation (SWIM). Now you are getting fractional hectares (stable assets) that increase in value over time. Probably needs an explanation too.
ITUP
Number sleven Number sleven 24 minutes ago
Zip, Market cap is not a factor, of damage calculation, in a patent infringement suite. It's about lost earnings. If the infringement is determined to be willfully, punitive damages are applied. (In the US) Three times the calculated damages. Hikma claimed that Vascepa sales were approaching a billi
AMRN
dennisdave dennisdave 30 minutes ago
I’m used to the share price tumbling… it really means little to me.
another sign you are in a cult not an investment
NWBO
trader53 trader53 30 minutes ago
NSAV - Chart Analysis

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166395631


NSAV - Cryptocurrency Play from 0.0001 to $0.0697
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162555114

_________________
MFI NSAV
Number sleven Number sleven 47 minutes ago
Zip, Nuke,
https://www.dennemeyer.com/ip-blog/news/how-are-damages-calculated-in-patent-infringement-cases/
Sleven,
AMRN
snow snow 49 minutes ago
RD I have some comments regarding the following statements: "These assets boast a low correlation with traditional holdings, offering stability amid market volatility. Enjoy sustained growth and shield your wealth when other markets waver."

To me it seems quite hazy what is meant by t
ITUP
powerwalker powerwalker 54 minutes ago
WOW! LTB, thanks for finding this and the same to TTT.

Now, for the peer review paper to be published.
AVXL
cojoboy cojoboy 59 minutes ago
Well said my man..!!👌👌👌
RONN
cojoboy cojoboy 1 hour ago
Indeed..Indeed..😎😎😎
RONN
helpx helpx 1 hour ago
we wait for Q2, if Alex gives us an income or he will tell us superb b.s as always
UATG

Your Recent History

TSX
HLS
HLS Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved